Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients

Table 3 Systolic function in HIV patients and control subjects (mean ± SD)

	HIV patients (n = 53)	Control subjects (n = 56)
M-mode measurements
LV-ED dimension (mm)	45.6 ± 5.9	46.2 ± 5.1
LV-ES dimension (mm)	31.1 ± 5.9	30.7 ± 6.5
LV-IS diastole (mm)	10.30 ± 2.03	9.90 ± 3.30
LV-IS systole (mm)	13.20 ± 2.85	13.10 ± 3.20
LV-PW diastole (mm)	9.06 ± 2.30	9.30 ± 2.50
LV-PW systole (mm)	12.9 ± 2.7	11.8 ± 3.1
B-mode measurements
EDV (mL)	107.6 ± 29.9	110.0 ± 33.6
ESV (mL)	44.2 ± 16.5	42.0 ± 17.1
LV-EF ( biplane Simpson's) (%)	63.3 ± 7.1	65.1 ± 8.2
SV (mL)	26.0 ± 20.8	24.6 ± 18.9
LV-ET (ms)	308.0 ± 40.8	306.0 ± 41.2

LV-ED: Left ventricular end diastole; LV-ES: Left ventricular end systole; LV-IS: Left ventricular interventricular septum; LV-PW: Left ventricular posterior wall; EDV: End-diastolic volume; ESV: End-systolic volume; LV-EF: Left ventricular ejection fraction; SV: Stroke volume; LV-ET: Left ventricular ejection time.